Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
August 09 2022
4-8 September: Defymed at the annual conference of the European Society for Biomaterials (ESB) Elisa...
June 03 2022
02 June 2022: Séverine Sigrist joins the French team of Women Leaders On May 10th, we invited you to...